Keywords: آسم شدید; Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
مقالات ISI آسم شدید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آسم شدید; Severe asthma; Exacerbations; Decline in lung function; FEV1; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; OCS; Oral corticosteroid;
Keywords: آسم شدید; Omalizumab; Severe asthma; Real-life; Therapeutic response; Age; Obesity; Comorbidities;
Keywords: آسم شدید; Severe asthma; Physical activity; Sedentary time; Accelerometry; Exercise capacity; Associations; Clinical outcomes; 6MWD; 6-minute walk distance; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; COPD; Chronic obstructive pul
Keywords: آسم شدید; Severe asthma; Anti-IL-5; mAb; Continuation; Response; ACQ-5; 5-item Asthma Control Questionnaire; IV; Intravenous; PARR; Placebo-adjusted rate ratio; RR; Rate ratio; RRNC; Rate ratio for noncontinuers; SC; Subcutaneous;
Keywords: آسم شدید; Severe asthma; Status asthmaticus; Healthcare resource utilization; Observational study; Cohort; ACT; Asthma Control Test; ACQ-5; Asthma Control Questionnaire-5 items; COBRA; “Cohorte Obstruction Bronchique et Asthme” cohort; GINA; Global Initiative f
Keywords: آسم شدید; Bradykinin; Bradykinin receptors; Asthma; Severe asthma; Airway inflammation; Airway remodelling;
Keywords: آسم شدید; Severe asthma; eosinophilia; autoantibodies; sputum; eosinophil degranulation; eosinophil peroxidase; autoimmunity; anti-nuclear antibodies; Abs600; Absorbance at 600Â nm; ANA; Anti-nuclear antibody; BAFF; B cell-activating factor of the TNF family; BCA
Keywords: آسم شدید; Oral corticosteroids; adverse effects; severe asthma; burst therapy; AE; Adverse effect; ICD-9; International Classification of Diseases, Ninth Edition; ICS; Inhaled corticosteroid; NCC; Number of chronic conditions (excluding asthma); OCS; Oral corticost
Keywords: آسم شدید; Adult-onset asthma; severe asthma; gene set variation analysis; phenotyping; transcriptomics; mechanisms; eosinophils; mast cells; ILC3; dES; Difference in enrichment scores; ES; Enrichment score; GSVA; Gene set variation analysis; ILC3; Group 3 innate ly
Keywords: آسم شدید; Severe asthma; Biologics;
Keywords: آسم شدید; Magnesium sulfate; High dose infusion; Severe asthma; Pediatric; Emergency department; Cost-effective; Sulfato de magnésio; Alta dose de infusão; Asma grave; Pediátrico; Serviço de emergência; Custo-benefÃcio;
Keywords: آسم شدید; Severe asthma; Qualitative study; St George's Respiratory Questionnaire; Patient-reported outcomes; Content validity; Health-related quality of life; AQLQ; Asthma Quality of Life Questionnaire; CAT; the COPD assessment test; CFC/HFA; chlorofluorocarbon hy
Keywords: آسم شدید; Severe asthma; 16s rRNA; Sputum; Bacterial spectrum;
Keywords: آسم شدید; Magnesium sulfate; High dose infusion; Severe asthma; Pediatric; Emergency department; Costâeffective; Sulfato de magnésio; Alta dose de infusão; Asma grave; Pediátrico; Serviço de emergência; CustoâbenefÃcio;
Keywords: آسم شدید; Bronchial asthma; severe asthma; near-fatal asthma; thunderstorm-related asthma; meteorological factors and asthma; prevention of thunderstorm-related asthma; asthma-related deaths;
Keywords: آسم شدید; Severe asthma; Patient reported outcome; St George's respiratory questionnaire; Psychometric properties; ACQ-5; Asthma Control Questionnaire-5; ANCOVA; analysis of covariance; ANOVA; analysis of variance; BDI-II; Beck Depression Inventory-II; CFA; confirm
Keywords: آسم شدید; Omalizumab; Severe asthma; Treatment duration; Real-life; Response; Effectiveness;
Keywords: آسم شدید; Mepolizumab; Omalizumab; Severe asthma; Exacerbations; Lung function; Tolerability; Crl; credible interval; HRQoL; health related quality of life; ITC; indirect treatment comparison; MEPO; mepolizumab; OCS; oral corticosteroid; OMA; omalizumab; RCT; rando
Keywords: آسم شدید; Asthma; Asthma diagnosis; Asthma assessment; Severe asthma; Asthma management; Difficult to treat asthma;
Keywords: آسم شدید; Asthma; Control; Biologics; Eosinophilic asthma; Severe asthma; Uncontrolled asthma; DDP-4; dipeptidyl peptidase 4; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting beta2 agonist; S
Keywords: آسم شدید; Biologic therapy; Comorbidities; Adherence; Inhaled corticosteroid; Phenotype; Severe asthma; ABPA; Allergic bronchopulmonary aspergillosis; AERD; Aspirin-exacerbated respiratory disease; COPD; Chronic obstructive pulmonary disease; CRS; Chronic rhinosinu
Keywords: آسم شدید; Severe asthma; Severe recurrent wheeze phenotypes; Children; Bacterial infection; Gastroesophageal reflux; Multiple allergies; BMI; Body mass index; FP; Fluticasone propionate; GERD; Gastroesophageal reflux; ICS; Inhaled corticosteroid; LTRA; Leukotriene
Keywords: آسم شدید; Childhood asthma; Phenotype; Refractory asthma; Severe asthma; Gene expression; Corticosteroid; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; inhaled corticosteroid; PBMC; peripheral blood mononuclear cell; SABA; shor
Keywords: آسم شدید; Severe asthma; Biologic therapy; Pharmacoeconomics; Health care resource use; Oral corticosteroid; Personalized medicine;
Keywords: آسم شدید; Severe asthma; Mepolizumab; Pharmacogenetics; Exacerbation;
Keywords: آسم شدید; Computed tomography; image processing; severe asthma; air trapping; image registration; luminal narrowing; wall thickening; airway circularity; cluster analysis; neutrophilic asthma; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; ADI; Anisot
Keywords: آسم شدید; Bronchial hyper-responsiveness; Equine asthma; Severe asthma; Lung; RNA sequencing;
Keywords: آسم شدید; Bronchial thermoplasty; difficult-to-control asthma; exacerbations; mepolizumab; omalizumab; phenotypes; severe asthma
Keywords: آسم شدید; Obstructive sleep apnea; Severe asthma; Exacerbations; Apnea-hypopnea index; Overlap syndrome;
Keywords: آسم شدید; Adult asthma; Severe asthma; Exacerbation; Smokers; Predictors; ACQ; asthma control questionnaire; AQLQ; asthma quality of life questionnaire; BMI; body mass index; FeNO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume in 1Â s; FVC; force
Keywords: آسم شدید; Difficult asthma; Severe asthma; Assessment; COPD; chronic obstructive pulmonary disease; OSA; obstructive sleep apnea; GORD; gastroesophageal reflux disease; Anx/Dep; anxiety/depression; DB; dysfunctional breathing; VCD; vocal cord dysfunction; ACT; Asth
Keywords: آسم شدید; Severe asthma; Epidemiology; Comorbidity; Risk factors; Clinical implications;
Keywords: آسم شدید; Severe asthma; Children; Lung function; Phenotype; Endotype; Inflammation; ATS; American Thoracic Society; FEV1; Forced expiratory volume in one second; FVC; Forced vital capacity; ICS; Inhaled corticosteroid; IgE; Immunoglobulin E; RV; Residual volume; S
Keywords: آسم شدید; Severe asthma; Biomarker; Eosinophil; Periostin; Exhaled nitric oxide; Endotype;
Keywords: آسم شدید; Antiasthma agents; Asthma control; Asthma cost; Asthma impairment; Asthma risk; Asthma guidelines; Controller medication; Persistent asthma; Severe asthma; CI; Confidence interval; ED; Emergency department; GERD; Gastroesophageal reflux disease; ICD-9; Th
Keywords: آسم شدید; Pediatric; severe asthma; steroid response; spirometry; inflammation; ACT; Asthma Control Test; BAL; Bronchoalveolar lavage; BDR; Bronchodilator reversibility; Feno; Fraction of exhaled nitric oxide; ICS; Inhaled corticosteroid; STRA; Severe therapy-resis
Keywords: آسم شدید; Hyperpolarized; 3He magnetic resonance imaging; ventilation defects; ventilation heterogeneity; severe asthma; childhood asthma; ATS; American Thoracic Society; CT; Computed tomography; FEF25-75; Forced expiratory flow rate from 25% to 75% of expired volu
Keywords: آسم شدید; Severe asthma; Biomarkers; Type-2 cytokines; Anti-IL-5; Anti-IL-13; Anti-IL-4&13;
Keywords: آسم شدید; Asthma; childhood asthma; dupilumab; inhaled corticosteroids; lebrikizumab; nitric oxide; mepolizumab; omalizumab; severe asthma;
Keywords: آسم شدید; Group 2 innate lymphoid cells; severe asthma; eosinophilic bronchitis; EoP; Eosinophilopoietic progenitor cell; HPC; Hematopoietic progenitor cell; ILC2; Group 2 innate lymphoid cell; IL-5R; IL-5 receptor; PE; Phycoerythrin; TSLP; Thymic stromal lymphopoi
Keywords: آسم شدید; Severe asthma; Chronic infection; Mycoplasma pneumoniae; Chlamydophila pneumoniae; Macrolides; Microbiome;
Keywords: آسم شدید; Asthma; Early asthma; Inhaled corticosteroids; Lebrikizumab; Mepolizumab; Omalizumab; Severe asthma; Tiotropium;
Keywords: آسم شدید; Severe asthma; Controller therapies; Add-on therapies; Guidelines; Nonbiologic therapies; Expert Panel Report 3 (EPR-3); Global Initiative for Asthma (GINA); European Respiratory Society and American Thoracic Society (ERS/ATS);
Keywords: آسم شدید; Ovalbumin; House dust mite; Severe asthma; Exacerbation; Viral infection;
Keywords: آسم شدید; Asthma; severe asthma; severe refractory asthma; difficult-to-control asthma; prevalence; ACQ; Asthma Control Questionnaire; COPD; Chronic obstructive pulmonary disease; ICS; Inhaled corticosteroid; IMI; Innovative Medicine Initiative; LABA; Long-acting Î
Keywords: آسم شدید; Severe asthma; Omalizumab; Biological; Anti-IgE; Difficult-to-control asthma; Hospitalisation; Emergency room; Asthmatic crisis; Asthma exacerbation
Keywords: آسم شدید; Severe asthma; Omalizumab; Asthma control; Exacerbations; Observational study
Keywords: آسم شدید; Severe asthma; Eosinophils; Airway remodeling; Asthma phenotypes; Asthma outcomes;
Keywords: آسم شدید; Systemic corticosteroids; severe asthma; health care use; dose response; corticosteroid-related complications; cost; CCI; Charlson Comorbidity Index; GEE; Generalized estimating equation; ICD-9-CM; International Classification of Diseases, Ninth Revision,